Fujian Aonong Biological Technology Group Incorporation Ltd (603363) - Total Assets
Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) holds total assets worth CN¥9.15 Billion CNY (≈ $1.34 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Fujian Aonong Biological Technology Grou (603363) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Fujian Aonong Biological Technology Group Incorporation Ltd - Total Assets Trend (2013–2024)
This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's total assets have evolved over time, based on quarterly financial data. Check 603363 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Fujian Aonong Biological Technology Group Incorporation Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Fujian Aonong Biological Technology Group Incorporation Ltd's total assets of CN¥9.15 Billion consist of 38.9% current assets and 61.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.6% |
| Accounts Receivable | CN¥1.13 Billion | 11.9% |
| Inventory | CN¥816.94 Million | 8.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥328.81 Million | 3.5% |
| Goodwill | CN¥345.39 Million | 3.6% |
Asset Composition Trend (2013–2024)
This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 603363 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fujian Aonong Biological Technology Group Incorporation Ltd's current assets represent 38.9% of total assets in 2024, a decrease from 70.7% in 2013.
- Cash Position: Cash and equivalents constituted 14.6% of total assets in 2024, down from 18.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 11.9% of total assets.
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Total Assets
Key competitors of Fujian Aonong Biological Technology Group Incorporation Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
United Plantations Bhd
KLSE:2089
|
Malaysia | RM3.47 Billion |
|
Yunnan Shennong Agricultural Industry Group Co Ltd
SHG:605296
|
China | CN¥7.16 Billion |
|
Zhongnongfa Seed Industry Group Co Ltd
SHG:600313
|
China | CN¥5.73 Billion |
|
Sipef NV
BR:SIP
|
Belgium | €1.21 Billion |
|
Graincorp Ltd
AU:GNC
|
Australia | AU$2.69 Billion |
|
Dharma Satya Nusantara Ptdsn
JK:DSNG
|
Indonesia | Rp17.76 Trillion |
|
Far East Holdings Bhd
KLSE:5029
|
Malaysia | RM1.91 Billion |
|
Jiangsu Hualv Biological Technology Co.Ltd.
SHE:300970
|
China | CN¥2.55 Billion |
Fujian Aonong Biological Technology Group Incorporation Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.02 | 0.19 | 0.56 |
| Quick Ratio | 0.76 | 0.12 | 0.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥75.29 Million | CN¥-9.91 Billion | CN¥-2.72 Billion |
Fujian Aonong Biological Technology Group Incorporation Ltd - Advanced Valuation Insights
This section examines the relationship between Fujian Aonong Biological Technology Group Incorporation Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.15 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -30.2% |
| Total Assets | CN¥9.51 Billion |
| Market Capitalization | $1.08 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Fujian Aonong Biological Technology Group Incorporation Ltd's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Fujian Aonong Biological Technology Group Incorporation Ltd's assets decreased by 30.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2024)
The table below shows the annual total assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥9.51 Billion ≈ $1.39 Billion |
-30.23% |
| 2023-12-31 | CN¥13.63 Billion ≈ $1.99 Billion |
-26.98% |
| 2022-12-31 | CN¥18.66 Billion ≈ $2.73 Billion |
+9.12% |
| 2021-12-31 | CN¥17.10 Billion ≈ $2.50 Billion |
+42.28% |
| 2020-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+144.20% |
| 2019-12-31 | CN¥4.92 Billion ≈ $720.19 Million |
+48.91% |
| 2018-12-31 | CN¥3.31 Billion ≈ $483.63 Million |
+30.22% |
| 2017-12-31 | CN¥2.54 Billion ≈ $371.40 Million |
+48.28% |
| 2016-12-31 | CN¥1.71 Billion ≈ $250.48 Million |
+26.96% |
| 2015-12-31 | CN¥1.35 Billion ≈ $197.29 Million |
+45.46% |
| 2014-12-31 | CN¥926.86 Million ≈ $135.63 Million |
+30.46% |
| 2013-12-31 | CN¥710.45 Million ≈ $103.96 Million |
-- |
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processi… Read more